| Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat CR Tate, LV Rhodes, HC Segar, JL Driver, FN Pounder, ME Burow, ... Breast Cancer Research 14, 1-15, 2012 | 298 | 2012 |
| Leptin produced by obese adipose stromal/stem cells enhances proliferation and metastasis of estrogen receptor positive breast cancers AL Strong, JF Ohlstein, BA Biagas, LV Rhodes, DT Pei, HA Tucker, ... Breast Cancer Research 17, 1-16, 2015 | 188 | 2015 |
| Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer LV Rhodes, SP Short, NF Neel, VA Salvo, Y Zhu, S Elliott, Y Wei, D Yu, ... Cancer research 71 (2), 603-613, 2011 | 179 | 2011 |
| Endocrine disruptor regulation of microRNA expression in breast carcinoma cells SL Tilghman, MR Bratton, HC Segar, EC Martin, LV Rhodes, M Li, ... PloS one 7 (3), e32754, 2012 | 178 | 2012 |
| Proteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migration C Zhou, Q Zhong, LV Rhodes, I Townley, MR Bratton, Q Zhang, EC Martin, ... Breast Cancer Research 14, 1-21, 2012 | 132 | 2012 |
| Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer LV Rhodes, EC Martin, HC Segar, DFB Miller, A Buechlein, DB Rusch, ... Oncotarget 6 (18), 16638, 2015 | 128 | 2015 |
| Antiestrogenic effects of the novel sphingosine kinase-2 inhibitor ABC294640 JW Antoon, MD White, WD Meacham, EM Slaughter, SE Muir, S Elliott, ... Endocrinology 151 (11), 5124-5135, 2010 | 127 | 2010 |
| Obesity associated alterations in the biology of adipose stem cells mediate enhanced tumorigenesis by estrogen dependent pathways AL Strong, TA Strong, LV Rhodes, JA Semon, X Zhang, Z Shi, S Zhang, ... Breast Cancer Research 15, 1-15, 2013 | 125 | 2013 |
| Adult human mesenchymal stem cells enhance breast tumorigenesis and promote hormone independence LV Rhodes, SE Muir, S Elliott, LM Guillot, JW Antoon, P Penfornis, ... Breast cancer research and treatment 121, 293-300, 2010 | 125 | 2010 |
| Effects of human mesenchymal stem cells on ER-positive human breast carcinoma cells mediated through ER-SDF-1/CXCR4 crosstalk LV Rhodes, JW Antoon, SE Muir, S Elliott, BS Beckman, ME Burow Molecular cancer 9, 1-15, 2010 | 122 | 2010 |
| Suppression of triple-negative breast cancer metastasis by pan-DAC inhibitor panobinostat via inhibition of ZEB family of EMT master regulators LV Rhodes, CR Tate, HC Segar, HE Burks, TB Phamduy, V Hoang, ... Breast cancer research and treatment 145, 593-604, 2014 | 96 | 2014 |
| Glyceollin I, a novel antiestrogenic phytoalexin isolated from activated soy MC Zimmermann, SL Tilghman, SM Boue, VA Salvo, S Elliott, KY Williams, ... Journal of pharmacology and experimental therapeutics 332 (1), 35-45, 2010 | 89 | 2010 |
| The histone deacetylase inhibitor trichostatin A alters microRNA expression profiles in apoptosis-resistant breast cancer cells LV Rhodes, AM Nitschke, HC Segar, EC Martin, JL Driver, S Elliott, ... Oncology reports 27 (1), 10-16, 2012 | 85 | 2012 |
| Human uterine smooth muscle and leiomyoma cells differ in their rapid 17β-estradiol signaling: implications for proliferation EN Nierth-Simpson, MM Martin, TC Chiang, LI Melnik, LV Rhodes, ... Endocrinology 150 (5), 2436-2445, 2009 | 78 | 2009 |
| Preferential star strand biogenesis of pre‐miR‐24‐2 targets PKC‐alpha and suppresses cell survival in MCF‐7 breast cancer cells EC Martin, S Elliott, LV Rhodes, JW Antoon, C Fewell, Y Zhu, JL Driver, ... Molecular carcinogenesis 53 (1), 38-48, 2014 | 59 | 2014 |
| Pharmacological inhibition of sphingosine kinase isoforms alters estrogen receptor signaling in human breast cancer JW Antoon, WD Meacham, MR Bratton, EM Slaughter, LV Rhodes, ... Journal of molecular endocrinology 46 (3), 205-216, 2011 | 59 | 2011 |
| Effects of 7-O substitutions on estrogenic and anti-estrogenic activities of daidzein analogues in MCF-7 breast cancer cells Q Jiang, F Payton-Stewart, S Elliott, J Driver, LV Rhodes, Q Zhang, ... Journal of medicinal chemistry 53 (16), 6153-6163, 2010 | 59 | 2010 |
| Glyceollins as novel targeted therapeutic for the treatment of triple-negative breast cancer LV Rhodes, SL Tilghman, SM Boue, S Wang, H Khalili, SE Muir, ... Oncology letters 3 (1), 163-171, 2012 | 53 | 2012 |
| Glyceollins as novel targeted therapeutic for the treatment of triple-negative breast cancer LV Rhodes, SL Tilghman, SM Boue, S Wang, H Khalili, SE Muir, ... Oncology letters 3 (1), 163-171, 2012 | 53 | 2012 |
| MEK5/ERK5 signaling suppresses estrogen receptor expression and promotes hormone-independent tumorigenesis JW Antoon, EC Martin, R Lai, VA Salvo, Y Tang, AM Nitzchke, S Elliott, ... PloS one 8 (8), e69291, 2013 | 52 | 2013 |
Matthew BurowTulane UniversityVerified email at tulane.edu
